NCT05356325View on ClinicalTrials.gov

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.

RecruitingOBSERVATIONAL
Enrollment

401

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Fibroblast Growth Factor 23AnemiaCKD
Trial Locations (1)

14004

RECRUITING

Hospital Universitario Reina Sofia, Córdoba

Sponsors
All Listed Sponsors
collaborator

Fondo de Investigacion Sanitaria

OTHER

lead

Maimónides Biomedical Research Institute of Córdoba

OTHER